Author
University Medical Center UtrechtORCID 0000-0003-4982-6914Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Anne L. Borst, Francisca J Bergsma, Femke van den Ham…·Judith Wienke
The paper identifies inhibitory Nectin-2/TIGIT interactions between CD163+ macrophages and CD8+ T cells in neuroblastoma tumor niches, linking them to poor patient outcomes.
Mariya Chernyavska, Karen Patricia Hartmann, Marco Jansen…·Wouter P. R. Verdurmen
This paper develops a retargeted adenovirus system to produce IgA antibodies and CD47 blockers in tumors, enhancing innate immune responses and reducing tumor volume in mice.
Elisabeth de Zeeuw, Laura M. Tool, Daniëlle Krijgsman…·Linda Gijzen
This study shows that targeting C2 reduces complement activation in human kidney ischemia-reperfusion injury models using 2D and 3D in vitro systems.
Maja Kowol, Marta Lustig, Annette M. Hartmann…·Thomas Valerius
This study evaluates the efficacy of CD38 and CD20 IgG1/IgA2 antibodies in mediating myeloid cell-mediated killing of B-ALL, showing enhanced activity with CD47/SIRPα blockade.